MindWalk Holdings (HYFT) Profit After Tax (2020 - 2026)
MindWalk Holdings (HYFT) reported Profit After Tax of -$17989.0 for Q1 2026, up 99.9% year-over-year from -$8999.1 in Q1 2025, and up 99.22% quarter-over-quarter from -$2.3 million in Q4 2025.
MindWalk Holdings (HYFT) Profit After Tax (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Profit After Tax data on file, last reported at -$17989.0 in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$17989.0, up 99.9% year-over-year; the trailing twelve-month figure through Jan 2026 was -$12.4 billion (down 25798.99% YoY), and the FY2025 annual result was -$24599.8, up 99.9% from the prior year.
- Profit After Tax improved to -$17989.0 in Q1 2026 per HYFT's latest filing, from -$2.3 million in the prior quarter.
- Over five years, Profit After Tax peaked at $2.9 million in Q3 2024 and troughed at -$12.4 billion in Q2 2025.
- A 5-year average of -$732.6 million and a median of -$3.1 million in 2024 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2023: Profit After Tax sank 277296.2% in 2022, then jumped 135.09% in 2023.
- A 5-year view of Profit After Tax shows it stood at -$5.6 million in 2022, then jumped by 65.65% to -$1.9 million in 2023, then sank by 62.01% to -$3.1 million in 2024, then advanced by 26.48% to -$2.3 million in 2025, then jumped by 99.22% to -$17989.0 in 2026.
- Business Quant data shows HYFT's Profit After Tax at -$17989.0 in Q1 2026, -$2.3 million in Q4 2025, and -$2910.4 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -56.74 Mn |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | -17,989.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -17,989.02 |
| Oct 31, 2025 | -2.30 Mn |
| Jul 31, 2025 | -2,910.41 |
| Apr 30, 2025 | -12.38 Bn |
| Jan 31, 2025 | -17.59 Mn |
| Oct 31, 2024 | -3.13 Mn |
| Jul 31, 2024 | 2.92 Mn |
| Apr 30, 2024 | -29.99 Mn |
| Jan 31, 2024 | -2.56 Mn |
| Oct 31, 2023 | -1.93 Mn |
| Jul 31, 2023 | 2.56 Mn |
| Apr 30, 2023 | -3.79 Mn |
| Jan 31, 2023 | -3.41 Mn |
| Oct 31, 2022 | -5.63 Mn |
| Jul 31, 2022 | -7.29 Mn |
| Apr 30, 2022 | -3.97 Mn |
| Jan 31, 2022 | -3.02 Mn |
| Oct 31, 2021 | -3,984.35 |
| Jul 31, 2021 | -2,629.17 |
| Apr 30, 2021 | -2.65 Mn |